Associate Sponsors

Co-sponsor

Home / India News / Biocon gets approval for Insulin Glargine

Biocon gets approval for Insulin Glargine

Image
Capital Market
Last Updated : Apr 10 2015 | 12:03 AM IST
LinkedIN IconFacebook Icon

From Mexican health authority, COFEPRIS

Biocon announced that its Insulin Glargine has been approved by COFEPRIS, the Mexican health authority, through its partner PiSA Farmaceutica (PiSA).

Powered by Capital Market - Live News

Connect with us on WhatsApp

More From This Section

India Lease Development announces resignation of director

Chembond Chemicals allots equity shares

Siti Cable Network announces resignation of director

Petronet LNG appoints director

First Published: Apr 09 2015 | 9:57 PM IST

Explore News

Next Story